Advertisement
Advertisement
IRD
Opus Genetics, Inc. Common Stock
3.24
USDSponsored
+0.16
+5.10%
Jul 27, 13:45 UTC -4
Open
IRD Earnings Reports
Positive Surprise Ratio
IRD beat 25 of 38 last estimates.
66%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
$2.49M
/-$0.15
Implied change from Q1 26 (Revenue/ EPS)
+15.55%
/-80.00%
Implied change from Q2 25 (Revenue/ EPS)
-13.52%
/+25.00%
Opus Genetics, Inc. Common Stock earnings per share and revenue
On May 12, 2026, IRD reported earnings of -0.75 USD per share (EPS) for Q1 26, missing the estimate of -0.14 USD, resulting in a -421.20% surprise. Revenue reached 2.16 million, compared to an expected 2.96 million, with a -27.15% difference. The market reacted with a +1.17% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 2.49 million USD, implying an decrease of -80.00% EPS, and increase of 15.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
NovoCure Limited Ordinary Shares
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.13
Surprise
+61.70%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
argenx SE - ADR
Report Date
Jul 23, 2026 For Q2 26
Estimate
$6.29
Actual
$7.32
Surprise
+16.38%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Opus Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Opus Genetics, Inc. Common Stock reported EPS of -$0.75, missing estimates by -421.2%, and revenue of $2.16M, -27.15% below expectations.
How did the market react to Opus Genetics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 1.17%, changed from $5.12 before the earnings release to $5.18 the day after.
When is Opus Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Opus Genetics, Inc. Common Stock's next earnings report?
Based on 5
analysts, Opus Genetics, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $2.49M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement